A detailed history of Sherbrooke Park Advisers LLC transactions in Biote Corp. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 16,217 shares of BTMD stock, worth $65,354. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,217
Previous 15,761 2.89%
Holding current value
$65,354
Previous $87.9 Million 13.96%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.04 - $6.93 $2,298 - $3,160
456 Added 2.89%
16,217 $100 Million
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $84,006 - $131,761
15,761 New
15,761 $87.9 Million

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $30.5M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.